Rallybio to Present at the Jefferies Healthcare Conference
01 June 2023 - 10:00PM
Business Wire
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage
biotechnology company committed to identifying and accelerating the
development of life-transforming therapies for patients with severe
and rare diseases, today announced that Company management will
participate in a fireside chat at the Jefferies Healthcare
Conference on Friday, June 9 at 9:00AM ET in New York, NY.
A live webcast of the fireside chat will be accessible through
the Events and Presentations section of Rallybio’s website at
www.rallybio.com. An archived replay of the webcast will be
available for 30 days following the presentation.
About Rallybio Rallybio (NASDAQ: RLYB) is a
clinical-stage biotechnology company with a mission to develop and
commercialize life-transforming therapies for patients with severe
and rare diseases. Rallybio has built a broad pipeline of promising
product candidates aimed at addressing diseases with unmet medical
need in areas of maternal fetal health, complement dysregulation,
hematology, and metabolic disorders. The Company has two clinical
stage programs: RLYB212, an anti-HPA-1a antibody for the prevention
of fetal and neonatal alloimmune thrombocytopenia (FNAIT) and
RLYB116, a C5 complement inhibitor with the potential to treat
several diseases of complement dysregulation, as well as additional
programs in preclinical development.
Rallybio is headquartered in New Haven, Connecticut with an
additional facility at the University of Connecticut’s Technology
Incubation Program in Farmington, Connecticut. For more
information, please visit www.rallybio.com and follow us on
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230531005790/en/
Investor Contacts Ami Bavishi Head of Investor Relations
and Communications 475-47-RALLY (Ext. 282)
abavishi@rallybio.com
Hannah Deresiewicz Stern Investor Relations, Inc. 212-362-1200
hannah.deresiewicz@sternir.com
Media Contact Tara DiMilia 908-369-7168
Tara.dimilia@tmstrat.com
Rallybio (NASDAQ:RLYB)
Historical Stock Chart
From Apr 2024 to May 2024
Rallybio (NASDAQ:RLYB)
Historical Stock Chart
From May 2023 to May 2024